Abstract Submission

IJMS - Abstract Submission

All accepted abstracts will be published in The International Journal of Medical Students (IJMS) as Supplement Issues of the Journal, which will be distributed to all participants.

10 best papers of SaMED will receive an official, direct invitation to submit their manuscript for publication in IJMS. All participants are encouraged to submit their papers by a general invitation.

Deadline for abstract submissions is 1st of January 2017!
You’ll be informed about the results of the abstract selection by the 15th of January 2017.

Guidelines for preparing the abstract

  • SaMED is welcoming research from all (bio)medical fields.
  • Abstract must contain original material.
  • Only abstracts in the English language will be reviewed.
  • Abstract will be published exactly as submitted and it is the responsibility of the presenting author to ensure accuracy of content and spelling.
  • Authors have to choose their presentation preferences: oral presentation or poster presentation.
  • After you submit your abstract you will receive a notification of abstract submission. Once abstract has been submitted it is final.
  • Late submissions will not be accepted.  

Formatting instructions:

  • The abstract should not exceed 300 words (including Background, Methods, Results and Conclusion).
  • The title must be short, clearly indicating the objective of the research. Only first letter of each word in the title should be capital. Do not include any abbreviations or commercial names of the drugs.
  • Full name of the first author should be written in CAPITAL LETTERS, and the name of co-author(s) in lower-case letters. Also, write the full address for correspondence.
  • Generic names should be used the first time a drug is mentioned and the proprietary name should be in brackets.
  • It is not permitted to include tables, charts or pictures in your abstract.
  • At the end of the abstract, please write 3 to 5 keywords that best describe your research.
  • Include references after the abstract.  

YOUR ABSTRACT SHOULD CONTAIN THE FOLLOWING PARTS:

  • TITLE:
  • AUTHORS AND FULL ADDRESS FOR CORRESPONDENCE:
  • BACKGROUND: Describe the current state of scientific progress regarding your field.
  • METHODS: Describe which methods and materials did you use to conduct your research.
  • RESULTS: Write only the most important results of your research.
  • CONCLUSION: Interpret the meaning of the results.
  • KEYWORDS: Write 3 to 5 keywords that best describe your research.
  • REFERENCES: Vancouver style.

DOWNLOAD TEMPLATE FOR ABSTRACTS

Submission Template - Abstract Submission

Abstract example

The Effects of Lead and Selenium on Melanoma Induction

ISABEL SÁ1*, Tânia Nogueira2, Elisabete Cunha1

1University of Vigo, Spain

2Faculty of Medicine University of Porto, Portugal.

*Corresponding author:

Isabel Sá
Address: Lagoas s/n,

                 36310 Vigo,

                 Pontevedra,

                 Spain
E-mail: maria.isabel.sa@hotmail.com

Abstract

Background: Melanoma is a malignant skin cancer and is one of the most aggressive malignancies in humans. Heavy metals, including lead, are known to cause cellular toxicity and have been studied for their potentials to induce apoptosis in tumor cells. Since selenium is considered to act protectively in cases of lead poisoning, this study focused on the effects of sodium selenite and lead chloride, both alone and combined, on melanoma cell apoptosis.

Methods: This study was carried out by doing cell culture of melanoma cells (B16-F10 cell line) and using C57BL/6 mice. Melanoma cells suspended in lead (II) chloride, sodium selenite,or lead (II) chloride+ sodium selenite solutions were injected subcutaneously to mice to induce tumor growth. After 12 days, tumors were excised and measured, followed by flow cytometry and a statistical analysis using a one-way ANOVA.

Results: In the group of mice receiving a single injection of melanoma cells suspended in 10 µmol/l of lead (II) chloride, the growth of tumor was significantly slower than in the control group. In mice treated with lead (II) chloride 50 µmol/l and 100 µmol/l, no tumor was visible at the end of the experiment. With a single injection of lead (II) chloride and sodium selenite at concentrations ≥10 µmol/l, the weight and size of the tumor were substantially smaller than in the control group.

Conclusion: The effect of lead (II) chloride on melanoma induction is dependent on the concentration of lead (II) chloride. Future applications may include the use of lead (II) chloride to increase apoptosis and necrosis in tumor cells and thus suppress tumor cells proliferation.

Keywords: Selenium; Lead; Melanoma; Apoptosis; Necrosis

How to prepare the presentation?

We have provided guidelines for both oral and poster presentations.

Learn more